Teriparatide Acetate
Published date: 2026-05-22 14:07:28
|
Name | pTH (1-34) (human) acetate salt | CAS# | 52232-67-4 |
|---|---|---|---|---|
| Price | $106.78/10mg $1877.39/1g | Purity | 99.69% | |
| Stocking Period |
3 Day | Stock | Inquiry | |
| Product Webpage: | http://www.zhaokebio.com | |||
| Detail
Product Information
Teriparatide is a recombinant human parathyroid hormone (PTH) analog consisting of the biologically active N-terminal portion of PTH (amino acids 1-34). It is the first and only anabolic osteoporosis therapy approved for the treatment of severe osteoporosis in postmenopausal women, men with primary or hypogonadal osteoporosis, and patients with glucocorticoid-induced osteoporosis. By stimulating osteoblast activity, Teriparatide increases bone mineral density (BMD) and improves bone microarchitecture, reducing the risk of vertebral and non-vertebral fractures. Product Highlights: First Anabolic Osteoporosis Therapy-Only anabolic (bone-building) agent among osteoporosis treatments; stimulates new bone formation by activating osteoblasts rather than merely inhibiting resorption. Addresses a critical unmet need for patients with severe osteoporosis who have failed anti-resorptive therapy. Clinically Proven Fracture Reduction-Pivotal trials demonstrate 65% reduction in vertebral fractures and 53% reduction in non-vertebral fractures vs placebo at 18-19 months. Strong clinical evidence supports premium pricing and broad formulary coverage in global markets. Large-Scale GMP Supply-Multi-kilogram GMP production capacity with validated recombinant peptide synthesis processes and comprehensive stability programs. Reliable commercial supply for formulation partners developing prefilled syringes, pen injectors, and multidose presentations. Biosimilar & Generic Development-Well-characterized reference standard available for biosimilar development programs pursuing interchangeability designation. Supports emerging market generic manufacturers and biosimilar developers with regulatory-compliant API and documentation. |